Poseida’s CAR T-cell Therapy Eradicates Previously Incurable Prostate Cancer in Mice

Poseida’s CAR T-cell Therapy Eradicates Previously Incurable Prostate Cancer in Mice
Poseida Therapeutics’ CAR T-cell therapy P-PSMA-101 eradicated a previously incurable type of human prostate cancer implanted in mice, the company reported. Another CAR T-cell therapy that has reached doctor’s offices has failed to counter the cancer, researchers said. The implication was that the improvements Poseida has introduced make a difference. Poseida’s founder and CEO, Eric

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

Leave a Comment

Your email address will not be published. Required fields are marked *